Sai Life Sciences Sustainability Report 2023

26 Corporate governance serves as the foundation of our commitment to long-term value creation, risk management and building trust with stakeholders. At Sai Life Sciences we perceive governance as a framework that goes beyond mere compliance; it shapes how we engage with shareholders, employees, customers and the wider community. Our governance practices are designed to promote integrity, transparency and accountability in all decision-making processes and actions. We have constituted six dedicated board committees with clearly defined terms of reference and scope for systemic management of our governance framework. Dr. K. Ranga Raju Chairman Executive Directors Krishna Kanumuri CEO & Managing Director *Joined in June 2023 Board of Directors Raju A Penmasta Director Mitesh Daga Investor Director Rajagopal S Tatta Independent Director Manjusha A Joshi* Independent Director Non Executive Directors Puneet Bhatia Investor Director Audit committee Oversee the company’s financial statements and auditors' reports Independent directors committee Responsible for monitoring the performance of the independent directors and assists the company in implementing best corporate governance practices Stakeholders’ relationship/investors grievance redressal committee Address and resolve the grievances of security holders of the company Nomination & remuneration committee Formulate criteria for qualification, appointment, remuneration and independence of the Board of directors Corporate social responsibility (CSR) committee Formulate and recommend Corporate Social Responsibility policy and programs and allocate CSR budget Vigil mechanism committee Report genuine concerns of directors and employees

RkJQdWJsaXNoZXIy MTIwMDc4NQ==